Notice for bulevirtide (Gilead Sciences Pty Ltd)
Active ingredients
bulevirtide
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Powder for injection
Indication
HEPCLUDEX is indicated for the treatment of chronic hepatitis delta virus (HDV) infection in adults with compensated liver disease
Therapeutic area
Infectious diseases